Body / AbdominalNuclear / MolecularNewsTrainee

18F-flotufolastat PET/MRI May Cut Prostate Biopsies Over 50%, Study Suggests

Reporting Systems watch (Google News)4d ago

Use of 18F-flotufolastat PET/MRI may reduce prostate biopsies by more than 50%, according to a new study covered by Diagnostic Imaging.

  • The news report highlights a study suggesting that the investigational PSMA-targeted PET tracer combined with MRI could cut prostate biopsy rates by over half.
  • No further details on study design, sample size, or confidence intervals were available in the source snippet.
Read the source

Also covered by

RadPigeon summaries are original and for information only. They are not clinical advice.